The Pharmacy Times® Asthma Resource Center is a comprehensive resource for clinical news and expert insights on issues related to the treatment of the chronic lung disease, in which the airways narrow and swell.
July 26th 2024
The molecule can be a potential treatment that counters effects of early-life antibiotics, which can impact the gut microbiota and increase the risk of childhood atopy and asthma.
Investigational Inhalational Therapy Shows Benefits Over Standard Asthma Treatment in Study
May 22nd 2019The new phase 2 data for an investigational once-daily, fixed dose combination currently in development for the treatment of inadequately controlled asthma was presented at the 2019 Annual International Congress of the American Thoracic Society (ATS) in Dallas.
Read More
Trellegy Ellipta Hits Phase 3 Asthma Marks, Eyes New Indication
May 5th 2019Pivotal phase 3 trial results show benefits for once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; Trelegy Ellipta) in patients with uncontrolled asthma compared with standard FF/VI (Breo Ellipta) therapy.
Read More
FDA Approves Dupilumab as Additional Maintenance Therapy in Certain Children with Asthma
October 22nd 2018The FDA has approved dupilumab (Dupixent®, Regeneron and Sanofi) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma.
Read More
Is There a Link Between Asthma and ADHD?
July 31st 2018Both asthma and attention-deficit/hyperactivity disorder (ADHD), both chronic conditions, have been associated with each other in previous studies, but questions remained as to the strength of the association because of other possible confounders.
Read More
Asthma Control Linked to Atrial Fibrillation Risk
July 23rd 2018A new research study, published in JAMA Cardiology, aimed to further confirm a previous correlation between asthma and atrial fibrillation (AF) and to determine if the degree of asthma control affected the risk of developing AF.
Read More